Oxybutynin Chloride Tablet
Product Images NDC 52817-261

4 FDA label images from Trupharma Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Oxybutynin Chloride (NDC 52817-261). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Trupharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Oxybutynin Chloride Tablets 1)

This Is An Image Of The Structural Formula For Oxybutynin Chloride. (Oxybutynin Chloride Tablets 1)
Chemical structure of oxybutynin chloride, displaying its molecular framework and functional groups as associated with this active ingredient in the product Oxybutynin Chloride tablets.*
FDA Label Image

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybutynin Chloride Tablets 2)

Figure 1. Mean R-oxybutynin Plasma Concentrations Following Three Doses Of Oxybutynin Chloride 5 mg Administered Every 8 Hours For 1 Day In 23 Healthy Adult Volunteers (Oxybutynin Chloride Tablets 2)
A line graph illustrating mean plasma R-oxybutynin concentration (ng/mL) over a 24-hour period following administration of oxybutynin 5 mg three times daily (TID). The x-axis represents time in hours, and the y-axis represents concentration levels, showing peaks after each dose and gradual declines in between.*
FDA Label Image

Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 (Oxybutynin Chloride Tablets 3)

Figure 2.mean Steady-state (±sd) R-oxybutynin Plasma Concentrations Following Administration Of Total Daily Oxybutynin Chloride Tablet Dose Of 7.5 mg To 15 mg (0.22 mg/kg To 0.53 mg/kg) In Children 5 (Oxybutynin Chloride Tablets 3)
A line graph showing mean R-Oxybutynin plasma concentration over time, measured in ng/mL, from 0 to 12 hours. Concentration peaks near 5 ng/mL around 1 hour, then gradually declines to below 1 ng/mL by 12 hours, with error bars indicating variability at each time point.*
FDA Label Image

Oxybutynin Chloride Tablets, Usp, 5 mg, 100 Count (Oxybutynin Chloride Tablets 4)

Oxybutynin Chloride Tablets, Usp, 5 mg, 100 Count (Oxybutynin Chloride Tablets 4)
Oxybutynin Chloride Tablets USP 5 mg oral tablets label from TruPharma LLC. Contains 100 tablets per bottle with Rx only designation. The label includes dosage information, storage instructions, manufacturer Tulex Pharmaceuticals, and distributor TruPharma LLC. Features a barcode and NDC 52817-260-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.